Advances in Study on Statins in Prevention of Colorectal Cancer / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 245-247, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-698181
ABSTRACT
Statins,the inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA)reductase,are mostly prescribed for the treatment of hyperlipidemia and prevention of cardiovascular events. Several studies have suggested that statins can reduce the risk of colorectal cancer,however,there is still a debate on its chemopreventive effect. This article summarized the local and overseas studies focusing on this issue,and made a brief overview on the effect of statins in prevention of colorectal cancer and adenoma and its potential mechanisms.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Gastroenterology
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS